top of page

Download my insightful White Paper titled: AI in Nutraceutical Formulation Opportunities, Limitations, and Scientific Responsibility. This comprehensive document explores the transformative role of AI in the nutraceutical industry, addressing both its potential and the ethical considerations involved. Don't miss the chance to enhance your understanding; click the link to access your copy today!


GLP-1 Anti-Obesity Drugs and Addiction: What New Research Is Revealing
In recent years, drugs acting on the GLP-1 system have become central to the treatment of obesity. Originally developed for diabetes, these medications (e.g., Wegovy and Mounjaro) have demonstrated remarkable efficacy in controlling appetite and promoting weight loss. Today, however, research is suggesting something even more intriguing: these drugs might also play a role in reducing the risk of addiction. A recent article published in Nature highlights findings from a larg
Claudia Gravaghi
Mar 92 min read


Why Many Nutraceutical Formulas Don’t Work: A Formulator’s Perspective
The nutraceutical industry is booming. Global demand for supplements supporting metabolism, sleep, cognitive performance, and longevity continues to grow every year. Yet a recurring problem remains: many nutraceutical formulas simply don’t work as well as they should. This is not because the ingredients themselves are ineffective. Many compounds used in supplements are supported by promising scientific research. The real issue often lies elsewhere in how these ingredients are
Claudia Gravaghi
Mar 54 min read


The Metabolic Hypothesis of Alzheimer’s Disease: Exploring New Frontiers
Alzheimer's disease has long been associated with amyloid plaques and tau tangles. However, recent metabolic research has shifted some focus toward insulin signaling dysfunction in the brain. This emerging perspective is crucial for understanding the complexities of Alzheimer’s. The concept of “type 3 diabetes” gained traction following the seminal 2008 paper by de la Monte & Wands . They described impaired insulin and IGF signaling in Alzheimer’s brains. Their findings propo
Claudia Gravaghi
Feb 174 min read


Understanding Supplement Formulation Cost Analysis
Creating a successful supplement product involves more than just selecting ingredients and packaging. One of the most critical aspects is understanding the costs involved in supplement formulation. These costs can significantly impact your product’s pricing, profitability, and market positioning. In this article, I will walk you through the key factors that influence supplement formulation costs, provide a detailed cost analysis, and offer practical advice to help you make in
Claudia Gravaghi
Feb 54 min read


Exploring the Role of GLP-1 Drugs in Transforming the Supplement Industry
The supplement industry is evolving rapidly, driven by new scientific discoveries and changing consumer demands. One of the most promising developments is the rise of GLP-1 drugs, originally designed for managing diabetes and obesity. These drugs are now gaining attention as potential companions to traditional supplements, offering new ways to support health and wellness. This post explores how GLP-1 drugs could reshape the supplement landscape and what that means for consume
Claudia Gravaghi
Jan 133 min read


Enhancing GLP-1 Effects: The Best Supplements and Companions to Consider
GLP-1 (glucagon-like peptide-1) plays a key role in managing blood sugar and appetite, making it a popular focus for people aiming to improve metabolic health. While GLP-1 receptor agonists are often prescribed for diabetes and weight management, certain supplements can support and enhance their effects. It is important to note that most people do not eat as much when taking GLP-1 drugs, which can further influence their nutritional needs. This post explores the best companio
Claudia Gravaghi
May 273 min read


Can AI Design Effective Supplements? A Formulator’s Perspective
Artificial intelligence is rapidly entering the world of nutraceuticals. From ingredient selection to trend analysis and product positioning, AI-driven tools promise to accelerate and optimise the formulation process. But can AI actually design effective supplements? The answer is more nuanced than it may seem. As a formulator working at the intersection of biochemistry, clinical nutrition, and product development, I see both the potential and the limitations of AI in this fi
Claudia Gravaghi
Apr 293 min read


EFSA Compliant Supplement Formulation: A Strategic Approach for EU/UK Brands
In early-stage supplement development, formulation is often approached as a question of ingredient prestige rather than regulatory intelligence . It is not uncommon to see product briefs heavily weighted toward branded, trademarked ingredients selected for their perceived innovation, exclusivity, or marketing appeal. At the same time, foundational nutrients such as vitamins and minerals are frequently overlooked, despite their proven efficacy and regulatory strength. From a
Claudia Gravaghi
Apr 132 min read


GLP-1 Drugs and Long-Term Safety: Side Effects, Muscle Loss, Tapering and Preventive Use
In recent years, GLP-1 receptor agonist medications such as Semaglutide and Tirzepatide have revolutionised the treatment of obesity and type 2 diabetes. Beyond improving glycemic control, these drugs induce significant weight loss by reducing appetite, slowing gastric emptying, and improving insulin sensitivity. However, while their effectiveness is well documented, the implications of long-term use deserve deeper consideration . In this article, we explore four aspects that
Claudia Gravaghi
Mar 243 min read
bottom of page